[<img src="https://media.phage.directory/capsid/2024-review/screenshot-2024-12-20-at-1-39-25-pm.png" alt="Podovirus Podcast!

Why don't we have phage therapy yet? We want to understand why. Come join the fun, with the new Podovirus podcast!

🎙️ Most recent episode: Joe and I interviewed Alexander (Sandro) Sulakvelidze, CEO of Intralytix, about his 26-year (!) journey toward getting phage cocktails on the market in the food industry, the 3 clinical trials they've got running, and the efficacy data (hopefully) around the corner!

🎧 Listen: Podovirus on Spotify

🎥 Watch: Podovirus on YouTube

Subscribe to get the next episodes!

💰On deck: two more phage + funding episodes coming soon!

Want some NIH money for phage work? Joe and I interviewed Kyung Moon, Program Officer at NIAID (and the one responsible for the new phage therapy center grant we're all probably contemplating applying for!)

We also interviewed Amanda Burkhardt and Mayukh Das, who are leading Phiogen Pharmaceuticals, a new Texas phage therapy company. We talk about drug pricing and how it applies to phages. In other words, how can we avoid phage companies going as bankrupt as antibiotics companies?!